H.C. Wainwright analyst Yi Chen raised the firm’s price target on LifeMD (LFMD) to $14 from $12 and keeps a Buy rating on the shares. The ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good afternoon. Thank you for joining us to discuss LifeMD, Inc.

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on LifeMD (LFMD – Research Report), with a price target of ...

LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid ...

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.12 per share a year ago. These figures are ...

LifeMD Inc (NASDAQ:LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue ...

Explore LifeMD stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LFMD. Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks ...

LifeMD (NASDAQ:LFMD – Get Free Report) is anticipated to announce its earnings results after the market closes on Monday, ...

Short interest in LifeMD Inc (NASDAQ:LFMD) increased during the last reporting period, rising from 4.79M to 5.11M. This put 14.18% of the company's publicly available shares short. Short interest ...

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...